奥赛康(002755) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the period was CNY 1,211,529,425.93, reflecting a decline of 1.87% year-on-year[8] - Net profit attributable to shareholders was CNY 251,214,764.01, an increase of 23.13% compared to the same period last year[8] - Net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 237,517,665.88, up 18.80% year-on-year[8] - Basic earnings per share for the period were CNY 0.2691, representing a growth of 22.43% compared to the previous year[8] - The weighted average return on net assets was 9.43%, an increase of 0.23% compared to the same period last year[8] - The company reported a total comprehensive income of ¥248,894,914.74, compared to ¥204,552,306.14 in the previous period, showing overall growth[60] - Net profit for the current period is ¥250,259,920.36, an increase of 22.8% compared to ¥203,791,649.19 in the previous period[58] - The net profit for the current period is 192,768,399.19, compared to 114,114,017.20 in the previous period, representing an increase of approximately 68.9%[83] Assets and Liabilities - Total assets at the end of the reporting period amounted to CNY 3,579,487,068.71, a decrease of 3.05% compared to the end of the previous year[8] - The total non-current assets reached ¥1,189,159,481.70, up from ¥1,057,179,599.36, indicating a growth of approximately 12.43%[39] - Current liabilities totaled ¥671,726,124.31, a decrease from ¥1,078,722,487.48, showing a reduction of about 37.7%[42] - The total liabilities decreased to ¥789,980,722.23 from ¥1,175,525,356.82, representing a decline of approximately 32.8%[42] - The total owner's equity rose to ¥2,789,506,346.48 from ¥2,516,571,684.77, marking an increase of about 10.8%[45] - Total liabilities amounted to ¥1,175,525,356.82, with non-current liabilities at ¥96,802,869.34[106] Cash Flow - The net cash flow from operating activities was CNY 191,967,983.91, an increase of 7.48% year-on-year[8] - Cash inflow from investment activities increased significantly to 210,000,000.00, up from 120,000,000.00 in the prior period, reflecting a strong investment return[93] - The cash flow from operating activities is 424,155,685.49, slightly down from 455,253,335.00 in the previous period, showing a decline of about 6.5%[86] - The cash flow from investment activities is -103,290,961.97, compared to -93,287,482.82 in the previous period, indicating a worsening of approximately 10.8%[89] - The cash flow from financing activities is -183,329,049.03, which is a larger outflow compared to -111,352,107.04 in the previous period, representing an increase in outflow of about 64.7%[89] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 23,784[12] - The top ten shareholders held a combined 81.36% of the company's shares, with the largest shareholder owning 34.20%[12] Expenses - Total operating costs decreased to ¥933,910,048.21 from ¥990,789,020.83, reflecting a cost reduction strategy[55] - Research and development expenses decreased to ¥68,631,586.86 from ¥76,763,851.83, suggesting a potential shift in R&D strategy[55] - Management expenses decreased by 44.50% to ¥111,597,630.05 as related expenditures were reduced due to the pandemic[20] - Sales expenses for the current period were ¥1,636,981,868.95, down 24.5% from ¥2,168,412,226.93 in the previous period[69] Investments - Long-term equity investments increased by 41.31% to ¥70,653,983.89 mainly due to investments in Lianyungang Guike Pharmaceutical[20] - Investment income rose by 123.99% to ¥2,689,942.79 due to increased investment income from associated companies[20] - The investment income for the current period is 210,000,000.00, compared to 120,000,000.00 in the previous period, representing an increase of about 75%[86] Government Support - The company received government subsidies amounting to CNY 25,395,423.97 during the reporting period[8] Changes in Accounting Standards - The company has implemented new revenue and leasing standards starting from 2020, which may impact future financial reporting[97] - The company has implemented new revenue and leasing standards starting from 2020, affecting prior comparative data[116]